The Green Organic Dutchman purchases strategic interest in Epican Medicinals

On June 14, 2018, The Green Organic Dutchman Holdings Ltd. ("TGOD") announced that it entered into a binding agreement to acquire 49.18% of Epican Medicinals Limited. ("Epican"), a strategic investment that will add an additional 14,000 kgs to TGOD's total organic funded capacity for a total of 130,000 kgs and establish a low-cost platform supplying TGOD with premium Jamaican grown medical cannabis for export to select international jurisdictions, as regulations permit.

In conjunction with the investment, TGOD also entered into a strategic partnership with Epican pursuant to which, among other things, TGOD and Epican will collaborate on the development of further organic cultivation capacity.

Further information can be found on Globe Newswire's website.

TGOD produces farm grown, pharma grade organic cannabis with sustainable, all natural principles. TGOD's products are laboratory tested to ensure patients have access to standardized, safe and consistent product. To date, TGOD has raised a total of $160 million, funding the expansion of 970,000 sq. ft. of state-of-the-art, ultra-high technology hybrid greenhouse facilities in Ancaster, Ontario and Valleyfield, Quebec. TGOD's facilities will be LEED certified and operate with close to a zero-carbon footprint with some of the lowest-cost power rates in the country.

Epican produces high quality cannabis at its primary Blue Mountain cultivation site and has partnered with TGOD to construct a second 125,000 sq. ft. GMP compliant facility. Upon receiving the second site license, both facilities will cultivate high premium organic strains for the Jamaican and international markets. TGOD will be working with Eco-Cert to achieve organic certification in Jamaica.